Danaher Corporation Share Price NYSE
Stocks
DHR PRB
US2358514097
Advanced Medical Equipment & Technology
| Market Cap | 166B 149B 137B 125B 236B 15,574B 243B 1,644B 655B 8,344B 623B 610B 26,378B | P/E 2026 * |
37.5x | P/E 2027 * | 31.4x |
|---|---|---|---|---|---|
| Enterprise Value | 187B 167B 154B 140B 265B 17,504B 273B 1,847B 736B 9,378B 701B 686B 29,646B | EV / Sales 2026 * |
7.11x | EV / Sales 2027 * | 6.44x |
| Free-Float |
70.57% | Yield 2026 * |
0.61% | Yield 2027 * | 0.67% |
Last Transcript: Danaher Corporation
| 1 day | -0.78% |
| Manager | Title | Age | Since |
|---|---|---|---|
Julie Montgomery
CEO | Chief Executive Officer | - | 30/09/2026 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 27/02/2026 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 30/06/1999 |
Steven Rales
CHM | Chairman | 74 | 31/12/1983 |
Mitchell Rales
BRD | Director/Board Member | 69 | 31/12/1983 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +1.02% | - | - | 166B | |
| -0.48% | +2.84% | +24.61% | +60.16% | 266B | |
| +0.42% | +2.61% | +11.81% | +19.85% | 166B | |
| -2.28% | +2.11% | -21.90% | +62.18% | 156B | |
| +1.54% | +2.76% | -55.70% | -13.30% | 64.79B | |
| -0.67% | +9.27% | +23.70% | +61.98% | 59.81B | |
| -0.07% | -4.06% | -3.15% | -9.26% | 53.3B | |
| -1.27% | +1.38% | +21.54% | +63.99% | 50.15B | |
| -0.28% | +0.77% | +3.31% | +85.09% | 49.47B | |
| -0.25% | +3.40% | +26.28% | +85.81% | 46.72B | |
| Average | -0.41% | +3.08% | +3.39% | +46.28% | 101B | |
| Weighted average by Cap. | -0.53% | +3.00% | +5.71% | +46.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.26B 23.55B 21.7B 19.71B 37.31B 2,462B 38.35B 260B 104B 1,319B 98.56B 96.47B 4,170B | 28.28B 25.36B 23.38B 21.23B 40.18B 2,652B 41.3B 280B 112B 1,421B 106B 104B 4,491B |
| Net income | 4.4B 3.94B 3.63B 3.3B 6.25B 412B 6.42B 43.51B 17.33B 221B 16.5B 16.15B 698B | 5.22B 4.68B 4.31B 3.91B 7.41B 489B 7.62B 51.61B 20.56B 262B 19.57B 19.16B 828B |
| Net Debt | 20.58B 18.45B 17.01B 15.45B 29.23B 1,929B 30.05B 204B 81.14B 1,034B 77.23B 75.59B 3,268B | 16.09B 14.43B 13.29B 12.07B 22.85B 1,508B 23.49B 159B 63.42B 808B 60.37B 59.09B 2,554B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
